Partial year: Data through Q3 2025 (Sept 30). Full-year totals not yet available.
GF

Gordon J. Freeman

DI Dana-Farber Cancer Institute: 2 patents #15 of 203Top 8%
Harvard University: 2 patents #27 of 403Top 7%
BC Beth Israel Deaconess Medical Center: 1 patents #5 of 75Top 7%
NA Novartis Ag: 1 patents #49 of 337Top 15%
UP University of Pennsylvania: 1 patents #43 of 262Top 20%
📍 Brookline, MA: #56 of 404 inventorsTop 15%
🗺 Massachusetts: #1,668 of 11,797 inventorsTop 15%
Overall (2025): #124,919 of 469,880Top 30%
2
Patents 2025

Issued Patents 2025

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
12258409 Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies Vassiliki Boussiotis, Xia Bu, Vikram Juneja, Arlene H. Sharpe, Nikolaos Patsoukis +2 more 2025-03-25
12186278 Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gerhard Frey, Jennifer Marie Mataraza +2 more 2025-01-07